From our earliest days of childhood, our exposure to certain species is confusing and contradictory, with animals like the beloved characters who fill our storybooks moulded into unrecognisable shapes and served up to us in deceptively happy packaging. With a recognition of this cognitive dissonance as a starting point, this report seeks to highlight the inconsistency of teaching children to love and respect animals whilst at the same time to accept the eating and usage of them.  Whilst the topic of animal farming is finally beginning to be taken seriously in conversations about environmental sustainability, its ethical implications for both humans and nonhumans remain massively overlooked. My project aims to bring the conversation about animal rights to the forefront of our moral considerations with childhood education as an entry point.  In collaboration with a primary school class (ages 9-11) and an animal sanctuary, I ran a three-part workshop designed to encourage interspecies thinking and provide a space for students to critically evaluate mainstream attitudes and assumptions towards nonhuman animals and, by extension, to question current norms surrounding animal use and consumption.

La persistance du VIH-1 est associée au maintien de l’inflammation chronique chez les patients infectés, malgré la mise en place de combinaison de traitements antirétroviraux. L’inflammation chronique est associée à un risque augmenté de développer des comorbidités, non associées au SIDA. Les polynucléaires neutrophiles (PNN) sont des cellules myéloïdes qui ont été impliqués dans de multiples maladies inflammatoires chroniques. Néanmoins, leur rôle dans l’infection par le VIH-1 est moins bien connue. Afin de pallier ce manque de connaissances, nous avons évalué l’hétérogénéité des PNNs dans le modèle macaque cynomolgus infecté par le SIVmac251. L’analyse phénotypique par cytométrie de masse a révélé la circulation de PNNs immatures en phase chronique de l’infection. En caractérisant l’hétérogénéité des PNNs au cours de l’infection par le SIV, nous avons observé une augmentation des fréquences des neutrophiles immatures et activés dans le sang dès la primo-infection. En phase chronique, les PNNs immatures et activés étaient toujours significativement augmentés dans le sang et la moelle osseuse. Au cours de l’infection, les PNNs avaient une fonction immunostimulatrice envers la prolifération et la sécrétion cytokinique des lymphocytaire T. L’initiation d’un traitement antirétroviral précoce a permis de restaurer le phénotype des PNNs. Les PNNs sont des cellules à fort potentiel pro-inflammatoire abondantes qui devraient être ainsi considérés comme de nouveaux effecteurs de l’inflammation chronique associée au VIH-1. / Even under combinational antiretroviral treatments (cART), HIV-1 persistence is associated with chronic inflammation in infected patients, leading to an increased risk of non-AIDS-related comorbidities. Polymorphonuclear neutrophils (PMN), have been less studied in HIV infection whereas they were associated with chronic inflammation diseases. To evaluate PMN heterogeneity in SIVmac251 nonhuman primate infection model, we first performed multiparameter single-cell phenotyping by mass cytometry giving a global vision of the immune system. This analysis demonstrated circulation of immature PMN with impaired during chronic infection. Then, we characterized neutrophils heterogeneity in the course of SIV infection. In primary infection, there was an increased frequency of CD10- immature and CD62L-low primed PMNs in peripheral blood. In chronic phase, CD10- immature PMNs were significantly higher in bone marrow and blood, maintaining a primed profile. During SIV infection, PMNs demonstrated variable immunomodulatory function against T cells proliferation and cytokine production. Early cART allowed to restore PMN phenotype. In this study, we provide unprecedented insight into PMN heterogeneity in the course of SIV infection. Since PMN represent 40-70% of circulating leukocytes and primed PMN are more potent to release pro-inflammatory cytokines and to transmigrate, they should be considered as a new player in HIV-1 chronic inflammation.

Carta al editor / Revisión por pares

The problematization of waste surplus informed numerous decisions on local, national and international levels. However, the waste pollution problem is far from being solved. This paper attempts to explore an alternative way of organizing waste using the Actor-Network Theory, which argues for equality between humans and nonhumans. We are taking this approach and recognising the role of waste as an essential actor in the decision-making process around waste management. Based on a case study of a second-hand shop, so-called Överskottet, where wasted materials are being transported and processed by people with special needs. We showcased how these alternative ways can be implemented. This shop is part of a collaboration between the Waste Management Department and the Social Services Department of Gotland’s municipality, namely, Region Gotland. This collaboration is a perfect example of the connection between the material and the social. In our study, we are analysing connections between waste and humans on different levels (i.e. municipality departments, humans and wasted materials) and show how these connections create a collaborative network that has both social and environmental impact. We account for factors that strengthen and factors that weaken, thus destabilising the collaboration network. Finally, we highlighted how these collaborations require adapting the existing policies surrounding waste management.

No description available.

No description available.

Abstract   This thesis investigates the interactions between human and nonhuman characters that express a particular concern regarding nature and the environment in Oscar Wilde's four fairy tales in A House of Pomegranates. The author utilizes a significant number of nonhuman characters to communicate with humans, which is a fairy-tale convention in which truth wins over falsehood, kindness is rewarded, and virtue triumphs over evil. However, Wilde's stories move beyond the fairy tale convention based on their ecocritical and political viewpoints. Based on a close reading of the four tales in Wilde's book, the thesis argues that the involvement of nonhuman characters, and their participation in events with human figures, raises several ecocritical matters. It also contends that nonhuman characters display interest in guiding human characters in their transformational journeys to support them in understanding that they all share one Earth and must be concerned about all species, nature, and the environment. Finally, this study argues that nonhuman characters communicate and talk mostly for their and nature’s rights, but sometimes they represent Victorians’ society. The analysis highlights the depth of the ecocritical approaches and how they are expressed in the texts. In addition, the discussions shed light on Victorian ecocriticism, including some theories and ideas of Anthropomorphism and Anthropocentrism within animal studies and transformation, which complete the analysis.

La transplantation d'organes est souvent la meilleure approche thérapeutique pour l'insuffisance organique au stade terminal. Le rejet de greffe est le principal obstacle pour une transplantation réussie, car cette dernière est le plus fréquemment réalisée entre individus génétiquement distincts. Les tissus ou organes transplantés sont généralement reconnus par le système immunitaire comme corps étrangers et sont rapidement détruits. Une série d'approches a été réalisée en clinique pour augmenter l'acceptation de la transplantation d’organes. Les immunosuppresseurs ont un rôle clé dans le combat contre le rejet de greffe. Actuellement, les résultats à court terme de la transplantation d'organes ont été considérablement améliorés avec l'émergence des inhibiteurs de la calcineurine (ICN), mais les résultats à long terme sont encore insatisfaisants. L'une des principales raisons est que les médicaments immunosuppresseurs actuels manquent de spécificité. Ces agents, en particulier ICN, sont considérés comme les facteurs de risque pour la perte tardive du greffon et les décès avec un greffon fonctionnel en raison de la toxicité des médicaments, de la sur-immunosuppression et d'autres effets secondaires. Ainsi, il y a un besoin urgent de rechercher de nouvelles thérapies idéales. Les lymphocytes T jouent un rôle central dans l'initiation du rejet des allogreffes. La pleine activation des cellules T nécessite au moins deux signaux combinés, mais distincts. En plus du signal généré par l'interaction entre le récepteur des cellules T (TCR) et les complexes CMH-peptides, le second signal, appelé signal de costimulation qui est délivré par l'engagement du récepteur de costimulation avec son ligand, est essentiel. L'engagement du TCR en l'absence de signaux de costimulation peut donner lieu à l'anergie des cellules T, un état d'absence de réponse immunitaire. Les molécules costimulatrices acquièrent ainsi l'attention en tant que cibles thérapeutiques potentielles. Du fait que ces molécules soient largement limitées à des cellules T et/ou des cellules présentatrices d'antigène, cibler la voie de signalisation de costimulation offre la possibilité de moduler le système immunitaire d'une manière plus sélective par rapport à des agents immunosuppresseurs conventionnels. À ce jour, de nombreuses molécules costimulatrices ont été identifiées et certaines ont été testées en tant que cibles thérapeutiques dans des modèles de transplantation d'organes. Les axes CD28–CD80/86 et CD40–CD40L sont importants et les deux voies de signalisation de costimulation les mieux connues. Bélatacept est un variant de l'antigène 4 des lymphocytes T cytotoxiques-immunoglobuline G (CTLA4-Ig) qui bloque la voie de signalisation CD28–CD80/86. C'est le seul bloqueur de la costimulation à être approuvé pour utilisation clinique en transplantation d'organes. Par rapport à la thérapie basée sur les ICN pour les receveurs de transplantation rénale, les thérapies à base de bélatacept montrent un taux similaire de survie, une fonction supérieure du greffon et l'amélioration du profil de risque cardiovasculaire. Cependant, bélatacept est également associée à des taux plus élevés de rejet aigu et de syndrome lymphoprolifératif post-greffe (SLPG). Dans notre étude, l'efficacité d'ASKP1240, un nouvel AcM anti-CD40 complètement humain qui bloque la voie de costimulation CD40–CD40L, a été évaluée sur la prévention du rejet d'allogreffe avec le modèle de transplantation rénale chez le singe cynomolgus. Quand ASKP1240 a été administré seul, il a réduit l'incidence du rejet aigu et a prolongé la survie de l'allogreffe rénale dépendamment de la dose administrée. L'acceptation de l'allogreffe rénale a été encore améliorée chez des singes qui ont reçus des traitements d'ASKP1240 combiné avec le tacrolimus (dose sub-thérapeutique) ou le mycophénolate mofétil (MMF). Le rejet aigu d'allogreffe a été totalement éliminé chez ces animaux et la médiane de survie du greffon rénal de ces groupes était significativement plus longue que ceux des groupes avec un traitement monothérapie. ASKP1240 a été bien toléré pour un traitement allant jusqu'à 180 jours. Il n'y avait pas d'effets secondaires évidents, y compris les complications thromboémboliques liées au médicament. L'administration d'ASKP1240 n'a pas induite de libération de cytokines. Ensuite, nous avons étudié les effets d'ASP2409 sur le rejet de l'allogreffe rénale et la survie chez des singes cynomolgus. ASP2409 est une nouvelle CD86-sélective variante de CTLA4-Ig, qui possède une affinité de liaison au CD86 14 fois plus élevée que le bélatacept in vitro et une amélioration de la puissance immunosuppressive. Une haute dose d'ASP2409 en monothérapie a montré des résultats supérieurs dans la réduction de rejet aigu et la prolongation de la survie de l'allogreffe rénale en comparaison avec une faible dose d'ASP2409 en monothérapie. Une faible dose d'ASP2409 en combinaison avec tacrolimus (dose sub-thérapeutique) inhibe complètement le rejet aigu d'allogreffe et prolonge significativement la survie de l'allogreffe rénale par rapport à une monothérapie avec une faible dose d'ASP2409 ou une dose sub-thérapeutique de tacrolimus. La médiane de survie de l'allogreffe des animaux recevant un traitement à base d'une dose élevée d'ASP2409, bélatacept, ou une dose thérapeutique de tacrolimus étaient identiques (> 91 jours). Les traitements à base d'une dose élevée d'ASP2409 présentaient de meilleurs résultats histopathologiques que le traitement à base de bélatacept. En outre, la fréquence des cellules FoxP3+ dans les allogreffes rénales a été observée plus haute dans les traitements à base d'ASP2409 et de bélatacept comparés aux traitements à base de tacrolimus. L'étude a également montré que ASP2409 est sans danger pour les animaux pour les doses qui ont été testées. Nous n'avons pas trouvé de graves effets secondaires liés à ASP2409 au cours des 91 jours d'étude. Collectivement, ces résultats suggèrent que la modulation sélective de la costimulation des cellules T avec des bloqueurs de la costimulation est une stratégie réalisable pour la prévention et le traitement du rejet d'allogreffe. ASKP1240 et ASP2409 sont tous deux des agents immunosuppresseurs prometteurs pour les régimes d'évitement ou de réduction des inhibiteurs de la calcineurine. / Organ transplantation is often the best therapeutic approach for end-stage organ failure. Graft rejection is the major obstacle to successful transplantation because transplantation is most frequently carried out between genetically distinct individuals. Transplanted tissues or organs are usually recognized by the immune system as foreign and are rapidly destructed without immune interventions. A series of approaches have thus been applied in clinic to inhibit the allogenic immune responses and in turn increase organ transplant acceptance. Immunosuppressive drugs are the key players in the "war" against immune cell-mediated rejection of allogenic transplants. Currently, the use of calcineurin inhibitors (CNIs) has dramatically decreased the risk of acute transplant rejection and improved the short-term outcomes of organ transplantation, but the long-term outcomes are still unsatisfied. One of the main reasons causing unsatisfied long-term outcomes is that current immunosuppressive drugs do not specifically target immune cells that cause transplant rejection. These immunosuppressive agents, especially CNIs, are the risk factors for late graft loss and death with functioning graft (DWFG) due to drug toxicity, over-immunosuppression, and other side-effects. Thus there is an urgent need for seeking novel therapies that can selectively eliminate the alloreactive immune responses while preserving the integrity of the remainder of the host immune system. It has been known that T cells play a central role in initiating allograft rejection. Full activation of T cells requires at least two collaborative but distinct signals. The first signal is generated by the interaction between T cell receptor (TCR) and MHC-peptide complex. The second signal, termed costimulatory signal, is delivered through the engagement of costimulatory receptors by their ligands. Importantly, TCR engagement in the absence of costimulatory signals can result in T cell anergy, a state of T cell unresponsiveness. Costimulatory molecules thus gain attention as potential therapeutic targets. Because these molecules are primary expressed on T cells and/or antigen-presenting cells, targeting costimulatory signaling pathway offers the oppertumities to modulate immune system in a more selective way relative to conventional immunosuppressive agents. To date, numerous costimulatory molecules have been identified and some have been tested as therapeutic targets in organ transplant models. CD28–CD80/86 and CD40–CD40L axis are two important and the most well known costimulatory signaling pathways. Belatacept, a variant of cytotoxic T lymphocyte antigen 4-immunoglobulin G (CTLA4-Ig) that blocks CD28–CD80/86 signaling pathway, is the only costimulation blocker to be approved for clinical use in organ transplantation. Compared to CNI-based regimen for kidney transplant recipients, belatacept-based regimens show similar patient and graft survival rate, superior graft function, and improved cardiovascular risk profile. However, belatacept is also associated with higher rates of acute rejection and posttransplant lymphoproliferative disorder (PTLD). Disruption of CD40–CD40L interaction with anti-CD40L mAbs has also been demonstrated to be a reliable approach for preventing acute rejection and for prolonging allograft survival. Unfortunately, unexpected thromboembolic complications in preclinical studies and clinical trials discontinued the development of anti-CD40L mAbs. The main objective of this thesis is to identify the optimal T cell costimulation blockers that can show improved safety and non-inferior efficacy in promoting allograft acceptance relative to current costimulatory blocking agents. Anti-CD40 mAbs are an alternative approach to block CD40–CD40L costimulatory pathway. CD40 is not involved in the stability of platelet thrombi and anti-CD40 mAbs are expected to not cause thromboembolic events. ASKP1240 is a novel fully human anti-CD40 mAb. In this study, the efficacy of ASKP1240 in the prevention of renal allograft rejection was evaluated in cynomolgus monkey kidney transplantation model. When ASKP1240 was administered alone, it dose-dependently reduced the incidence of acute rejection and prolonged renal allograft survival. Renal allograft acceptance was further improved in the monkey which received regiments using ASKP1240 combined with conventional immunosuppressive drugs tacrolimus (sub-therapeutic dose) or mycophenolate mofetil (MMF). Acute allograft rejection was totally eliminated in these animals and the kidney allograft median survival times (MST) of these groups were significantly longer than those of monotherapy groups. ASKP1240 administration did not induce cytokine release. This agent was well tolerated in monkey kidney transplant recipients during the 180-day treatment period. There were no obvious side effects including drug-related thromboembolic complications. Next, we tested the hypothesis that a CD86-selective variant of CTLA4-Ig might show non-inferior efficacy on the prevention of allograft rejection and prolongation of graft survival in comparison with belatacept. CD86 is the dominating ligand between the two natural ligands for CD28 in alloimmune response. Improvements in CD86 binding affinity of CTLA4-Igs confer increased immunosuppressive potency. A CD86-selective CTLA4-Ig variant may reach therapeutic levels of CD86 occupancy while occupies substantially less CD80 ligand than non-CD86-selective CTLA4-Igs. Preservation of CD80 signaling may be favoring to retain protective immunity and to improve safety of CTLA4-Ig therapy. This thesis investigated the effects of a novel CD86-selective CTLA4-Ig variant, ASP2409, on renal allograft rejection and survival in cynomolgus monkeys. ASP2409 possesses 14-fold higher in vitro CD86 binding affinity than belatacept and improved immunosuppressive potency. Compared to no-treatment control, low-dose (0.3 mg/kg) ASP2409 monotherapy significantly prolonged renal allograft survival (MST = 5 and 26 days, respectively) but did not decrease the incidence of acute rejection (8/8). The rate of acute renal allograft rejection was reduced in the group of high-dose ASP2409 monotherapy (2/7) and, correspondingly, a much longer MST (>91 days) was shown in this group. Combination therapy of low-dose ASP2409 and tacrolimus (sub-therapeutic dose) completely eliminated acute allograft rejection and notably prolonged renal allograft survival (MST >91 days). The MSTs of renal allografts in the animals receiving high-dose ASP2409-, belatacept-, and therapeutic dose tacrolimus-based immunosuppressive regimens were same (>91 days). High-dose ASP2409-based regimens exhibited better histopathological results than belatacept-based regimen. Furthermore, higher frequencies of FoxP3+ Tregs in renal allografts were observed in ASP2409- and belatacept-based regimens compared to tacrolimus-based regimen. ASP2409 was also demonstrated to be safe for animals with the doses to be tested. There were no serious side effects related to ASP2409 to be found in term of 91-day study. This study demonstrates that ASKP1240 is as effective as anti-CD40L mAbs on inhibition of acute rejection and prolongation of renal allograft survival, and do not cause thromboembolic complications. Previous studies indicated that CNIs could diminish the effects of anti-CD40L mAbs. In our study, ASKP1240 in combination with tacrolimus or MMF shows improved efficiency. Furthermore, the effects of ASP2409 on promoting renal allograft acceptance are not inferior to belatacept. These results collectively suggest that ASKP1240 and ASP2409 both are the promising immunosuppressive agents for solid organ transplantation.

Este trabalho teve como objetivo estudar o desenvolvimento do comportamento manipulativo em macacos-prego (Cebus apella) em semiliberdade, com ênfase na ontogênese do comportamento de quebra de cocos. A coleta de dados foi realizada ao longo de dois anos e meio, o que permitiu um acompanhamento longitudinal dos filhotes com idade inferior a dois anos. As dinâmicas sociais relacionadas à aprendizagem de quebra também foram estudadas. Os resultados mostram que os macacos começaram a manipular objetos com cerca de um mês de idade e conseguiram quebrar cocos com sucesso a partir dos dois anos. Eles observaram seus co-específicos quebrando cocos, sendo que os maiores observadores foram os imaturos, especialmente os juvenis. Os alvos de observação foram preferencialmente aqueles macacos que apresentaram uma maior taxa de quebra. Durante a observação de co-específicos, houve raros registros de agonismo, ou seja, há grande tolerância social. Houve intercalação entre brincadeira e quebra de cocos por macacos imaturos. Grande parte da aquisição do comportamento de quebra de cocos pode ser atribuída às experiências individuais, mas também há oportunidades para que ocorra a aprendizagem social por meio de observação direta do co-específico proficiente, já que os observadores são bem tolerados. / The objective of this work was to study the manipulative behavior of semifree-ranging tufted-capuchin monkeys (Cebus apella), focusing on the ontogenesis of nutcracking behavior. Data collection was done during a period of two years and a half, and so, a longitudinal study with monkeys under two-years old could be performed. Social dynamics related to nutcracking learning were also studied. The results show that the monkeys started manipulating objects when they were around a month of age, but only subjects over two years of age were able to sucessfully crack nuts. They observed conspecific nutcracking: immature monkeys were the main observers, especially juveniles. The main targets of observation were the monkeys who had the highest nutcracking rate. Agonism was rare during conspecific observation, what means that social tolerance was high. There were events in which immature monkeys alternated play and nutcracking behavior. An important part of nutcracking acquisition can be attributed to individual experiences, but there are also opportunities for social learning through direct observation of proficient conspecific, once observers are well tolerated.

A quebra de frutos encapsulados por macacos-prego com o auxílio de ferramentas é tipicamente objeto de observação e scrounging por coespecíficos, bastante tolerados e em geral mais jovens e menos proficientes. O presente estudo teve como objetivo examinar o processo de escolha, pelos observadores, dos alvos de observação, e se esta escolha pode otimizar as oportunidades de scrounging. A pesquisa foi realizada com um grupo de macacos-prego selvagens (Cebus libidinosus) na Fazenda Boa Vista (Piauí - Brasil), numa área de ecótono cerrado/caatinga. A partilha de alimento fora dos episódios de quebra de cocos e o uso de ferramentas para a quebra de outros itens alimentares encapsulados também foram abordados. Indivíduos de todas as classes de idade e sexo se envolveram na observação da quebra de cocos, havendo uma grande variação individual. Nossas análises mostram que os macacos preferencialmente escolhidos como alvos de observação foram aqueles que apresentaram maior Freqüência, Proficiência e Produtividade na quebra de cocos. Apesar de haver interações agonísticas durante os eventos de observação, os alvos se mostram muito tolerantes à observação e ao scrounging - 25% dos episódios de quebra são observados e mais da metade destes eventos de observação resultam em scrounging. Os observadores tiveram a oportunidade de comer os restos dos cocos e de manipular os itens do sítio de quebra. Estas observações reforçam a noção de que as condições e possibilidades vivenciadas pelo observador-scrounger otimizam as oportunidades para que ocorram processos de aprendizagem socialmente mediada, ao menos por realce de estímulo. Tal exposição próxima ao comportamento do alvo poderia influenciar aspectos mais finos do comportamento dos observadores, ao longo de sua história de aprendizagem. O presente estudo aborda estas interações entre manipuladores de ferramentas e observadores/scroungers pela primeira vez em uma população selvagem e discute as semelhanças e discrepâncias em relação aos resultados anteriormente obtidos com uma população em semil-liberdade. / The tool-aided cracking of encapsulated fruit by capuchin monkeys is a frequent target of observation and scrounging by conspecifics, well-tolerated and usually younger and less proficient. The present study aimed to examine the process of observational targets choice by the observers, and whether this choice can optimize scrounging opportunities. The research was conducted with a group of wild bearded capuchin monkeys (Cebus libidinosus) in Fazenda Boa Vista (Piauí, Brazil), in an ecotone area between cerrado and caatinga savanna-like environments. Food sharing in contexts other than nut cracking, as well as the use of tools to crack open other food items were also analyzed. Individuals from all age and sex classes were involved in nut cracking observation. Our analyses show that the monkeys preferentially chosen as observational targets were the ones exhibiting the greater Frequency, Proficiency, and Productivity in nut cracking. In spite of a few agonistic interactions during observation events, the targets tend to be very tolerant to observation and to scrounging (25% of the nut cracking events are observed, and more than half of these resulted in scrounging). The observers had the opportunity of eating nuts leftovers and of manipulating items from the cracking sites, both in the presence and in the absence of the targets. These findings strengthen the idea that the conditions and possibilities experienced by the observers-scroungers optimize the opportunities for socially biased learning processes, at least by stimulus enhancement. Such close exposure to the targets behavior could also influence finer details of the observers behavior in the long run. The present study is the first one to deal with these interactions between tool manipulators and observers/scroungers in a wild population and discusses the similarities and differences from previous observations from a semi-free population.